M&A

Expecting Big Pharma buyers to come running after weakened AstraZeneca? Not so fast
Fierce Pharma
Tue, 08/1/17 - 11:12 pm
AstraZeneca
M&A
Pfizer
Awaiting tax reform clarity, Pfizer delays potential M&A
Drug Delivery Business News
Tue, 08/1/17 - 10:59 pm
taxes
Pfizer
M&A
Does Puma's quick Nerlynx launch play into its buyout prospects?
Fierce Pharma
Tue, 08/1/17 - 11:30 am
Puma Biotechnology
Nerlynx
breast cancer
M&A
5 Things Gilead Sciences' Q2 Earnings Numbers Didn't Tell You
Motley Fool
Mon, 07/31/17 - 09:59 pm
Gilead Sciences
earnings
hepatitis C
HIV
M&A
Court Ruling on 'Biosimilars' Sets Stage for More Drug Acquisitions
TheStreet.com
Sun, 07/30/17 - 09:44 am
biosimilars
M&A
R&D
Supreme Court
Prescribed Reading: Pharma marked by restructuring and failures
BioPharma Dive
Fri, 07/28/17 - 10:40 pm
restructuring
M&A
AstraZeneca
Mystic
AstraZeneca Takeover Chatter Bubbles Up Again After Massive Drug Trial Disappointment
TheStreet.com
Thu, 07/27/17 - 11:56 am
AstraZeneca
Mystic
clinical trials
M&A
Pfizer
Merck
With $39B in cash and biosim threats looming, could Amgen use a deal? Executives say not yet
Fierce Pharma
Wed, 07/26/17 - 10:36 pm
Amgen
biosimilars
M&A
These 2 Pharma Giants May Be on Pfizer's M&A Radar Right Now
Motley Fool
Wed, 07/26/17 - 11:22 am
Pfizer
M&A
AstraZeneca
Bristol-Myers Squibb
Lilly puts two-thirds of midphase cancer pipeline up for sale in major shake-up of R&D priorities
Fierce Biotech
Tue, 07/25/17 - 10:27 am
Eli Lilly
M&A
oncology
R&D
Johnson & Johnson rolls Pulsar Vascular, Neuravi into new Cerenovus neurovascular biz
Mass Device
Tue, 07/25/17 - 08:25 am
JNJ
M&A
Pulsar Vascular
Neuravi
Cerenovus
devices
A new wave of pharma mergers could put innovative drugs in the pipeline
Stat
Mon, 07/24/17 - 11:07 am
M&A
R&D
innovation
Biotech M&A? Novartis chief Jimenez says he’s sticking to the under-$1B aisle for now
Endpoints
Wed, 07/19/17 - 10:29 am
Novartis
M&A
Pharma CEOs
Joe Jimenez
GSK puts old antibiotics and UK Horlicks business on the block
Yahoo/Reuters
Wed, 07/19/17 - 09:34 am
GSK
antibiotics
MaxiNutrition
M&A
5 Ways Gilead Sciences Could Spend Its Cash Hoard
Motley Fool
Wed, 07/19/17 - 10:24 am
Gilead Sciences
dividends
share repurchase
M&A
debt
Valeant's debt-fueled castoffs continue with half-priced Obagi sale
Fierce Pharma
Mon, 07/17/17 - 06:47 pm
Valeant Pharmaceuticals
Obagi
M&A
Abbott launches tender offer for Alere in $5.3B merger
Drug Delivery Business News
Mon, 07/17/17 - 11:02 am
Abbott Labs
Alere
diagnostics
devices
M&A
These 3 Charts Don't Lie: Gilead Sciences Needs an Acquisition
Motley Fool
Mon, 07/17/17 - 08:49 am
Gilead Sciences
M&A
Tesaro's rumored buyers aren't biting. Should Gilead go for Incyte instead?
Fierce Pharma
Sat, 07/15/17 - 11:14 am
Tesaro
Gilead Sciences
Incyte
M&A
Pining for a megadeal, an analyst kicks the tires for another Gilead M&A test drive
Endpoints
Fri, 07/14/17 - 11:28 am
M&A
Gilead Sciences
Incyte
Vertex Pharmaceuticals
John Milligan

Pages